Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol)
Version 3 2024-06-18, 07:49
Version 2 2024-06-03, 20:47
Version 1 2018-01-01, 00:00
journal contribution
posted on 2024-06-18, 07:49 authored by PK Ellegaard, RW Licht, HE Poulsen, RE Nielsen, Michael BerkMichael Berk, Olivia DeanOlivia Dean, Mohammadreza MohebbiMohammadreza Mohebbi, CT NielsenAdd-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol)
History
Related Materials
- 1.
Location
GermanyOpen access
- Yes
Link to full text
Language
EnglishPublication classification
C Journal article, C1 Refereed article in a scholarly journalCopyright notice
2018, The AuthorsJournal
International Journal of Bipolar DisordersVolume
6Article number
ARTN 11Pagination
1 - 9ISSN
2194-7511eISSN
2194-7511Issue
1Publisher
SPRINGERUsage metrics
Keywords
Science & TechnologyLife Sciences & BiomedicinePsychiatryBipolar disorderDepressionAcetylcysteineOxidative stressInflammationUrineBloodTreatmentGeneticsACETYL-CYSTEINE TREATMENTTERM SPATIAL MEMORYGLUTATHIONE DEPLETIONOXIDATIVE STRESSDISORDERSSCALEDNARELIABILITYSYMPTOMSVALIDITY110999 Neurosciences not elsewhere classified920410 Mental HealthFaculty of HealthSchool of MedicineInstitute for Innovation in Mental and Physical Health and Clinical Translation3209 Neurosciences3202 Clinical sciences4203 Health services and systems200409 Mental health420313 Mental health services
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC